SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-004194
Filing Date
2021-02-04
Accepted
2021-02-04 08:10:20
Documents
7
Period of Report
2021-02-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eq-8k_20210203.htm 8-K 53447
2 EX-4.1 eq-ex41_7.htm EX-4.1 82825
3 EX-5.1 eq-ex51_11.htm EX-5.1 17956
4 EX-10.1 eq-ex101_6.htm EX-10.1 70486
5 EX-99.1 eq-ex991_10.htm EX-99.1 12894
6 GRAPHIC gq02uwg53uke000001.jpg GRAPHIC 20331
7 GRAPHIC ge5lc4fpjsv5000001.jpg GRAPHIC 14505
  Complete submission text file 0001564590-21-004194.txt   287218
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 21588916
SIC: 2834 Pharmaceutical Preparations